Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed3
Recruiting1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02654483Phase 2Completed
Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients
Epidermolysis BullosaPruritus
PrincipalinvestigatorStart date: 2016-08-31
NCT01263379Phase 1/2Completed
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Epidermolysis BullosaEpidermolysis Bullosa Dystrophica
PrincipalinvestigatorStart date: 2010-10-05
NCT01019148Recruiting
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Epidermolysis Bullosa Dystrophica
PrincipalinvestigatorStart date: 2009-11-10

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02654483Phase 2PrincipalInvestigator

Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

Epidermolysis BullosaPruritus
Completed
NCT01263379Phase 1/2PrincipalInvestigator

Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa

Epidermolysis BullosaEpidermolysis Bullosa Dystrophica
Completed
NCT01019148PrincipalInvestigator

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Epidermolysis Bullosa Dystrophica
Recruiting
NCT01666002Not ApplicablePrincipalInvestigator

Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser

Onychomycosis
Completed

All 4 trials loaded